Expression of Matrix Metalloproteinases and Its Inhibitor in Gastric Adenocarcinoma
Related Experiment Video
Updated: Mar 28, 2026
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Purpose:
Matrix metalloproteinases (MMPs) have been associated with tumor cell invasion and metastasis by mediating the degradation of extracellular matrix components. A tissue inhibitor of metalloproteinases (TIMPs) has been reported to inhibit tumor invasion by means of an inactivation of matrix metalloproteinases. An imbalance between MMPs and the associated TIMPs may play a significant role in the invasive phenotype of malignant tumors. Therefore, MMPs and their inhibitors constitute promising agents for developing anticancer therapies. In the present study, the authors investigated the correlation between the expressions of TIMP-1 and MMPs, and the clinical outcome.
Materials And Methods:
Immunohistochemical staining of MMP-2, -3 and -9, and TIMP-1 was performed on paraffin-embedded tissue sections of 38 early gastric carcinomas and 61 advanced gastric carcinomas.
Results:
MMP-2 and -9 were found mainly in tumors of the intestinal type and less frequently in those of diffuse type. There were positive correlations between the presence of MMP-2 and -9 and lymph node status. There were inverse correlations between the TIMP-1 expression and tumor invasiveness.
Conclusion:
These results suggests that clinical outcomes such as the depth of invasion or metastasis are closely related to the expression of TIMP-1, MMP-2 and MMP-9.
Insights
Tumor invasion and metastasis correlate with matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). This study found TIMP-1 expression inversely correlates with tumor invasiveness, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Biochemistry
- Cancer Biology
Background:
- Matrix metalloproteinases (MMPs) degrade extracellular matrix, aiding tumor invasion and metastasis.
- Tissue inhibitors of metalloproteinases (TIMPs) counteract MMPs, potentially inhibiting tumor spread.
- An imbalance between MMPs and TIMPs is implicated in malignant tumor invasiveness.
Purpose of the Study:
- To investigate the correlation between TIMP-1 and MMP expression (MMP-2, -3, -9) and clinical outcomes in gastric cancer.
- To explore the potential of MMPs and TIMPs as therapeutic targets for anticancer strategies.
Main Methods:
- Immunohistochemical staining was performed on 38 early and 61 advanced gastric carcinoma tissue sections.
- Expression levels of MMP-2, MMP-3, MMP-9, and TIMP-1 were analyzed.
Main Results:
- MMP-2 and MMP-9 expression was higher in intestinal-type gastric tumors compared to diffuse-type.
- Positive correlations were observed between MMP-2 and MMP-9 presence and lymph node metastasis.
- Inverse correlations were found between TIMP-1 expression and tumor invasiveness.
Conclusions:
- Clinical outcomes, including invasion depth and metastasis, are significantly associated with the expression of TIMP-1, MMP-2, and MMP-9.
- These findings highlight the critical roles of TIMP-1, MMP-2, and MMP-9 in gastric cancer progression.
- The study suggests potential for targeting these molecules in gastric cancer therapy.
Related Concept Videos
01:23Role of Matrix Metalloproteases in Degradation of ECM
02:17The Tumor Microenvironment